We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App

Roche Showcases Innovative Laboratory Solutions and Digital Diagnostics

By LabMedica International staff writers
Posted on 21 May 2023
Print article
Image: The cobas 5800 molecular diagnostics system expands access to testing and improves patient care (Photo courtesy of Roche Diagnostics)
Image: The cobas 5800 molecular diagnostics system expands access to testing and improves patient care (Photo courtesy of Roche Diagnostics)

Roche Diagnostics (Basel, Switzerland) is showcasing innovative laboratory solutions and digital diagnostics through - "Innovation Past, Present and Future" at this year's WorldLab-EuroMedLab 2023 in Rome, Italy, 21-25 May. Attendees can experience first-hand Roche's latest technological advancements in lab automation, serum work area, molecular and point of care solutions, and discover how the company is transforming patient care through advancements in breakthrough high-medical value diagnostic and digital solutions.

At the 2023 EuroMedLab Congress, Roche is featuring new innovations, such as several molecular systems from the growing PCR portfolio – the cobas 5800 and the new LightCycler PRO System, which will be launched later this year. A prototype for the new cobas Mass Spec system is being unveiled, bringing mass spectrometry into the routine testing environment. The system complements the serum work area portfolio, allowing healthcare communities to benefit in the future from an extended diagnostic platform offering clinical chemistry, heterogeneous immunoassays, and mass spectrometry.

The new cobas connection modules (CCM Vertical), a flexible modular system that makes effective utilization of lab space and seamlessly integrates into the existing cobas connection modules, improving lab efficiency, is also being featured at the industry event. Roche is also introducing its navify digital solutions to the laboratory community that are designed to fulfill the laboratories' need for seamless and secure connectivity between systems, instruments and even devices from different providers, as well as empowering lab leaders to drive operational efficiencies and help clinicians gain greater medical insights.

"With the ever-changing needs of the healthcare system, laboratories, and clinicians are expected to optimize laboratory operations and efficiencies while improving patient care," said Ann Costello, Head of Roche Diagnostics Solutions at Roche Diagnostics. "We are pleased to present the next generation of innovative solutions that simplify and streamline testing for laboratories of all sizes, throughputs, and disciplines while supporting clinical decision-making to improve patient care."

"Laboratories have a unique opportunity to connect siloed data across systems and points of care for greater insights," said Moritz Hartmann, Head of Roche Information Solutions at Roche Diagnostics. "At Roche, we are working closely together with lab leaders to enable more patient-centered care. Our navify portfolio of integrated digital solutions enables open digital ecosystems that connect to innovations, drive operational efficiencies, and generate actionable insights for improved patient care."

Related Links:
Roche Diagnostics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Plasma Control
Plasma Control Level 1

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more


view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.